CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today reported preliminary fourth quarter 2015 results. The Company also announced that it has completed the transfer to manufacturing of its ePlex system and initiated analytical studies in support of European launch.
